Compounds > l-3-(3-hydroxy-4-pivaloyloxyphenyl)alanine
Page last updated: 2024-09-05

l-3-(3-hydroxy-4-pivaloyloxyphenyl)alanine and Dyskinesia, Drug-Induced

l-3-(3-hydroxy-4-pivaloyloxyphenyl)alanine has been researched along with Dyskinesia, Drug-Induced in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iversen, SD; Miyaji, M; Naruse, T; Rupniak, NM; Tye, SJ1

Other Studies

1 other study(ies) available for l-3-(3-hydroxy-4-pivaloyloxyphenyl)alanine and Dyskinesia, Drug-Induced

ArticleYear
NB-355: a novel prodrug for L-DOPA with reduced risk for peak-dose dyskinesias in MPTP-treated squirrel monkeys.
    Clinical neuropharmacology, 1989, Volume: 12, Issue:5

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Levodopa; Motor Activity; Parkinson Disease, Secondary; Prodrugs; Saimiri; Time Factors

1989